Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Sallmon, H; Koehne, P; Hansmann, G.
Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus.
Clin Perinatol. 2016; 43(1):113-29
Doi: 10.1016/j.clp.2015.11.008
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Sallmon Hannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A patent ductus arteriosus (PDA) is associated with several adverse clinical conditions. Several strategies for PDA treatment exist, although data regarding the benefits of PDA treatment on outcomes are sparse. Moreover, the optimal treatment strategy for preterm neonates with PDA remains subject to debate. It is still unknown whether and when PDA treatment should be initiated and which approach (conservative, pharmacologic, or surgical) is best for individual patients (tailored therapies). This article reviews the current strategies for PDA treatment with a special focus on recent developments such as oral ibuprofen, high-dose regimens, and the use of paracetamol (oral, intravenous).
- Find related publications in this database (using NLM MeSH Indexing)
- Acetaminophen - therapeutic use
- Administration, Intravenous - administration & dosage
- Administration, Oral - administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
- Cardiac Catheterization - methods
- Ductus Arteriosus, Patent - therapy
- Humans - administration & dosage
- Ibuprofen - therapeutic use
- Indomethacin - therapeutic use
- Infant, Newborn - administration & dosage
- Infant, Premature - administration & dosage
- Infant, Very Low Birth Weight - administration & dosage
- Intensive Care Units, Neonatal - administration & dosage
- Ligation - administration & dosage
- Find related publications in this database (Keywords)
- Patent ductus arteriosus
- Preterm infant
- Very low birth weight
- Ibuprofen
- Indomethacin
- Paracetamol